Leave No One Behind: Using a Benefit-Based Advance Market Commitment to Incentivise Development and Global Supply of COVID-19 Vaccines
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-06-30
Type
Web Page
Author
Kalipso Chalkidou
Author
Hannah Kettler
Author
Ganesh Ramakrishnan
Author
Rachel SIlverman
Author
Adrian Towse
URL
https://www.cgdev.org/publication/leave-no-one-behind-using-benefit-based-advance-market-commitment-covid-vaccine
Date
07/05/2020
Extra
Library Catalog: www.cgdev.org
Accessed
2020-06-30 19:11:24
Language
en
Abstract
The global effort to control the COVID-19 pandemic has seen an exceptional allocation of public and philanthropic funds to advance the development of diagnostics, therapeutics, and vaccines as quickly as possible. While critical, even these significant commitments represent only a “down payment” on a price tag that could eventually exceed $50 billion just to scale the production of vaccines to control this global pandemic—amounts that cannot be raised through traditional donor and philanthropic commitments.
Website Title
Center For Global Development
Short Title
Leave No One Behind